Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

Int J Lab Hematol. 2018 Dec;40(6):e105-e108. doi: 10.1111/ijlh.12870. Epub 2018 Jun 19.

Authors

A-S Dincq¹, S Lessire¹, G Pirard¹, R Siriez², M Guldenpfennig³, J Baudar³, J Favresse³, J Douxfils^{2

4}, F Mullier³

Affiliations

¹ Department of Anestesiology, CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Université catholique de Louvain, Yvoir, Belgium.
² Department of Pharmacy, Namur Research Institute for LIfe Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.
³ CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Université catholique de Louvain, Yvoir, Belgium.
⁴ QUALIblood sa, Namur, Belgium.

PMID: 29920946
DOI: 10.1111/ijlh.12870

No abstract available

Publication types

Letter

MeSH terms

Centrifugation / methods
Factor Xa Inhibitors / analysis
Humans
Pyrazoles / analysis*
Pyridones / analysis*
Rivaroxaban / analysis*
Time Factors

Substances

Factor Xa Inhibitors
Pyrazoles
Pyridones
apixaban
Rivaroxaban